Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5088975018 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid vaccine | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5088976017 | Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5088977014 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid only vaccine product | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | est un(e) (attribut) | Haemophilus influenzae type b capsular polysaccharide antigen conjugated only vaccine product | true | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | a pour principe actif (attribut) | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Act-HIB 10 micrograms per 0.5 milliliter powder and diluent for solution for injection Sanofi Pasteur Limited (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | Inferred relationship | Some | |
| Hiberix 10 micrograms per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | Inferred relationship | Some | |
| Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure) | substance utilisée (attribut) | True | Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR